1. South Korea Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Miwon Holdings Co.Ltd.

Miwon Holdings Co.Ltd.

KKRX:107590
57,700.00
KRW
+100.00
(+0.17%)
25,667.65EPS
2.37P/E
123.88BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
36,749.98
38,087.85
38,878.38
1,431.38
32,955.95
60,894.89
80,786.89
124,390.66
181,949.1
215,670.14
191,409.61
205,831.18
212,787.02
239,444.61
Basic EPS, GAAP
4,329.3
3,634
4,403.5
518.78
3,562.54
4,154.9
6,590.55
7,557
14,308
8,717
5,708
10,906
11,302
22,576.3
Free Cash Flow per Basic Share
1,360.94
1,041.74
2,938.04
429.39
-5,928.53
3,095.2
-1,137.78
9,369.07
7,204.29
-1,514.18
1,236.59
3,579.25
11,295.38
18,761.45
Dividend per Share
- -
250.43
- -
25.59
1,010.82
- -
625.68
9,533.17
4,530.3
1,013.65
1,395.37
1,493.35
1,545.91
1,456.14
Book Value per Share
21,006.51
24,195.62
28,278.57
33,017.04
53,644.68
56,573.46
62,937.41
70,127.81
87,326.95
95,465.68
100,782.68
112,415.61
125,023.73
144,401.26
Tangible Book Value per Share
20,728.84
23,927.08
28,012.03
32,464.41
53,079.8
55,962.7
61,528.15
68,732.37
85,958.02
94,126.93
99,416.06
111,009.93
123,525.05
142,865.67
Basic Weighted Avg Shares
7
7
7
66
4
2
2
2
2
2
2
2
2
2
Sales/Revenue/Turnover
263,343
273,941
270,442
95,126
117,568
141,971
188,377
288,971
421,386
499,293
443,162
476,576
492,718
554,422
Operating Margin (%)
14.52
12.19
13.64
2.71
7.8
2.54
4.12
7.54
7.05
4.57
3.51
4.83
4.13
6.48
Depreciation Expense
7,993
9,763
10,179
10,743
4,998
1,669
3,096
6,805
6,100
5,974
7,556
8,720
9,099
9,159
Net Income, GAAP
31,023
26,137
30,631
34,477
12,709
9,687
15,368
17,556
33,137
20,181
13,215
25,251
26,170
52,274
Effective Tax Rate (%)
20.36
23.86
21.76
28.96
52.46
26.14
19.66
21.88
22.59
- -
- -
15.01
15.49
12.84
Profit Margin (%)
11.78
9.54
11.33
36.24
10.81
6.82
8.16
6.08
7.86
4.04
2.98
5.3
5.31
9.43
Working Capital
88,548
105,615
116,852
124,514
16,880
19,522
42,917
29,773
25,353
20,402
23,715
35,456
39,159
64,392
LT Debt
- -
- -
- -
- -
- -
28,315
46,725
44,617
53,017
65,747
72,451
61,988
44,504
37,924
Total Equity
151,346
172,466
192,424
216,536
122,367
132,068
197,611
198,267
235,758
256,304
269,929
297,586
326,721
373,890
Return on Invested Capital (%)
21.77
15.19
15.35
0.87
2.49
1.85
2.99
6.55
7.81
- -
- -
4.97
4.16
7.04
Return on Capital (%)
22.85
16.09
16.73
16.75
7.35
6.83
7.37
4.88
9.32
- -
- -
6.49
6.16
10.9
Return on Common Equity (%)
22.95
16.14
16.79
16.86
7.5
7.62
11.03
11.35
18.16
9.54
5.82
10.23
9.52
17.19

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
47,630
49,694
53,776
LT Borrowings
41,435
38,602
35,731
LT Finance Leases
3,069
2,661
2,193
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
2
Market Capitalization
156,293
148,189
123,877

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
170,713
204,780
236,795
Cash, Cash Equivalents & STI
18,133
17,030
37,646
Accounts Receivable, Net
59,567
93,598
98,587
Inventories
88,328
82,801
92,508
Total Current Liabilities
131,554
156,963
172,403
Payables & Accruals
- -
- -
- -
ST Debt
47,630
49,694
53,776
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.99%
10.6%
9.79%
Free Cash Flow
-124.67%
15.81%
215.6%
Net Income, GAAP
10.84%
21.97%
3.64%
Sales/Revenue/Turnover
12.96%
12.8%
3.39%
Total Cash Common Dividend
- -
-16.4%
3.53%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
122,250
120,871
117,421
116,034
476,576
2025
128,402
118,085
128,202
118,029
492,718
2026
147,711
160,480
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4,364
4,103
2,423
16.08
10,906
2025
4,060
2,428
3,914.42
900.08
11,302
2026
5,866.32
11,895.48
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,126.79
105.22
2.84
258.53
1,493.35
2025
513.71
700.14
- -
332.21
1,545.91
2026
759.51
364.43
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Jong Kook Son
Full Time Employees
21
Sector
Process industries
Industry
Chemicals: specialty
Address
20, Poeun-daero 59beon-gil Yongin-si GY South Korea 16864
IPO Date
Mar 2, 2009
Website
miwonsc.com
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
PI Industries Limited (NSE:PIIND)
Business
Miwon Holdings Co., Ltd. (107590.KS) is a South Korea-based holding company principally engaged in the manufacture and marketing of specialty chemicals, with a focus on UV/EB curing systems, surfactants, hardened resins, and advanced materials for electronics and personal care industries. The company offers acrylate monomers, methacrylate monomers, oligomers, photoinitiators, and ingredients for UV/EB formulations; surfactants for personal and home care products; hardened resins; polymer additives; photosensitizers and semiconductor materials; energy curing solutions; and high-refractive index lens monomers, supplied through subsidiaries including Miwon Specialty Chemical Co., Ltd. and affiliates such as Dongnam Chemical and Miwon Commercial Co., Ltd.. Founded in 1959 with corporate headquarters in Yongin-si, Gyeonggi-do, South Korea, Miwon Holdings operates globally across 13 locations in regions including Asia, Europe (with a production plant in Catalonia, Spain established in 2014), and other international markets, generating significant overseas sales comprising approximately 59% of revenue in recent years.. Formerly known as Miwon Specialty Chemical Co., Ltd., the company restructured into its current holding form around 2017 and has pursued growth through strategic acquisitions, including a W18 billion stake in affiliate Dongnam Chemical from Miwon Commercial in recent years and integration of Taekwang Fine Chemical, alongside investments like a 9 million euro expansion of its European plant in Catalonia announced in 2025..